175 related articles for article (PubMed ID: 8832669)
1. Na2B12H11SH (BSH) in combination with systemic hyaluronidase: a promising concept for boron neutron capture therapy for glioblastoma.
Haselsberger K; Radner H; Pendl G
Neurosurgery; 1996 Aug; 39(2):321-5; discussion 325-6. PubMed ID: 8832669
[TBL] [Abstract][Full Text] [Related]
2. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.
Goodman JH; Yang W; Barth RF; Gao Z; Boesel CP; Staubus AE; Gupta N; Gahbauer RA; Adams DM; Gibson CR; Ferketich AK; Moeschberger ML; Soloway AH; Carpenter DE; Albertson BJ; Bauer WF; Zhang MZ; Wang CC
Neurosurgery; 2000 Sep; 47(3):608-21; discussion 621-2. PubMed ID: 10981748
[TBL] [Abstract][Full Text] [Related]
3. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma.
Kageji T; Nagahiro S; Kitamura K; Nakagawa Y; Hatanaka H; Haritz D; Grochulla F; Haselsberger K; Gabel D
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):120-30. PubMed ID: 11516861
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
[TBL] [Abstract][Full Text] [Related]
6. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT).
Haritz D; Gabel D; Huiskamp R
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1175-81. PubMed ID: 8175403
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.
Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Asano T; Kirihata M; Ono K; Kuroiwa T
J Neurooncol; 2006 Jul; 78(3):227-32. PubMed ID: 16557351
[TBL] [Abstract][Full Text] [Related]
8. Boron neutron capture therapy of brain tumors: functional and neuropathologic effects of blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
Yang W; Barth RF; Rotaru JH; Boesel CP; Wilkie DA; Bresnahan JC; Hadjiconstantinou M; Goettl VM; Joel DD; Nawrocky MM
J Neurooncol; 2000 Jul; 48(3):179-90. PubMed ID: 11100816
[TBL] [Abstract][Full Text] [Related]
9. Subcellular biodistribution of sodium borocaptate (BSH: Na2B12H11SH) in a rat glioma model in boron neutron capture therapy.
Kageji T; Nagahiro S; Otersen B; Gabel D; Nakaichi M; Nakagawa Y
J Neurooncol; 2002 Sep; 59(2):135-42. PubMed ID: 12241106
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer.
Ichikawa H; Taniguchi E; Fujimoto T; Fukumori Y
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S111-4. PubMed ID: 19376721
[TBL] [Abstract][Full Text] [Related]
11. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
Gregoire V; Begg AC; Huiskamp R; Verrijk R; Bartelink H
Radiother Oncol; 1993 Apr; 27(1):46-54. PubMed ID: 8327732
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy.
Doi A; Kawabata S; Iida K; Yokoyama K; Kajimoto Y; Kuroiwa T; Shirakawa T; Kirihata M; Kasaoka S; Maruyama K; Kumada H; Sakurai Y; Masunaga S; Ono K; Miyatake S
J Neurooncol; 2008 May; 87(3):287-94. PubMed ID: 18219552
[TBL] [Abstract][Full Text] [Related]
13. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment with buthionine sulfoximine enhanced uptake and retention of BSH in brain tumor.
Yoshida F; Yamamoto T; Nakai K; Zaboronok A; Matsuda M; Akutsu H; Ishikawa E; Shirakawa M; Matsumura A
Appl Radiat Isot; 2014 Jun; 88():86-8. PubMed ID: 24731546
[TBL] [Abstract][Full Text] [Related]
15. Disposition of TF-PEG-Liposome-BSH in tumor-bearing mice.
Ito Y; Kimura Y; Shimahara T; Ariyoshi Y; Shimahara M; Miyatake S; Kawabata S; Kasaoka S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S109-10. PubMed ID: 19395268
[TBL] [Abstract][Full Text] [Related]
16. Boron neutron capture therapy for glioblastoma: improvement of boron biodistribution by hyaluronidase.
Haselsberger K; Radner H; Pendl G
Cancer Lett; 1998 Sep; 131(1):109-11. PubMed ID: 9839625
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of sodium borocaptate: a critical assessment of dosing paradigms for boron neutron capture therapy.
Gibson CR; Staubus AE; Barth RF; Yang W; Ferketich AK; Moeschberger MM
J Neurooncol; 2003; 62(1-2):157-69. PubMed ID: 12749711
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors.
Kageji T; Nakagawa Y; Kitamura K; Matsumoto K; Hatanaka H
J Neurooncol; 1997 May; 33(1-2):117-30. PubMed ID: 9151229
[TBL] [Abstract][Full Text] [Related]
20. Boron neutron capture therapy: boron biodistribution and pharmacokinetics of Na2B12H11SH in patients with glioblastoma.
Haselsberger K; Radner H; Pendl G
Cancer Res; 1994 Dec; 54(24):6318-20. PubMed ID: 7987820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
